(Q46028716)

18 December 2017

title

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM. (English)

1 reference

18 December 2017

0 references

0 references

Paolo Frigio Nichelli

8

1 reference

18 December 2017

Jessica Mandrioli

object named as

Jessica Mandrioli

2

1 reference

ORCID Public Data File 2021

Patrizia Sola

1

object named as

Patrizia Sola

1 reference

18 December 2017

author name string

Anna M Simone

3

1 reference

18 December 2017

Diana Ferraro

4

1 reference

18 December 2017

Roberta Bedin

5

1 reference

18 December 2017

Rosanna Annecca

6

1 reference

18 December 2017

Maria G Venneri

7

1 reference

18 December 2017

Elisa Merelli

9

1 reference

18 December 2017

publication date

15 November 2010

1 reference

18 December 2017

Multiple Sclerosis Journal

published in

1 reference

18 December 2017

volume

17

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

303-311

1 reference

18 December 2017

Defining the clinical course of multiple sclerosis: Results of an international survey

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Primary-progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

The immunopathology of multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Immunologic factors in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

A sensitive and reproducible method for the detection of oligoclonal IgM bands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

The natural history of primary progressive MS in British Columbia, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Natural history of multiple sclerosis: a unifying concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

The natural history of primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

The immunology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Lymphoid neogenesis in chronic inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510386996

21 January 2018

Identifiers

DOI

10.1177/1352458510386996

1 reference

18 December 2017

PubMed ID

21078694

1 reference

18 December 2017